HomeInsightsStock Comparison

Abbott India Ltd vs Pfizer Ltd Stock Comparison

Abbott India Ltd vs Pfizer Ltd Stock Comparison

Last Updated on: Jun 09, 2025

Key Highlights

  • The Latest Trading Price of Abbott India Ltd is ₹ 31763 as of 09 Jun 09:58.
  • The P/E Ratio of Abbott India Ltd changed from 55.4 on March 2020 to 47.7 on March 2024 . This represents a CAGR of -2.95% over 5 yearsThe P/E Ratio of Pfizer Ltd changed from 36.2 on March 2020 to 34.8 on March 2024 . This represents a CAGR of -0.79% over 5 years.
  • The Market Cap of Abbott India Ltd changed from ₹ 32842 crore on March 2020 to ₹ 57260 crore on March 2024 . This represents a CAGR of 11.76% over 5 yearsThe Market Cap of Pfizer Ltd changed from ₹ 18411 crore on March 2020 to ₹ 19184 crore on March 2024 . This represents a CAGR of 0.83% over 5 years.
  • The revenue of Abbott India Ltd for the Mar '25 is ₹ 1680 crore as compare to the Dec '24 revenue of ₹ 1686 crore. This represent the decline of -0.32% The revenue of Pfizer Ltd for the Mar '25 is ₹ 809.3 crore as compare to the Dec '24 revenue of ₹ 580.75 crore. This represent the growth of 39.35%.
  • The ebitda of Abbott India Ltd for the Mar '25 is ₹ 504.56 crore as compare to the Dec '24 ebitda of ₹ 507.84 crore. This represent the decline of -0.65% The ebitda of Pfizer Ltd for the Mar '25 is ₹ 444.89 crore as compare to the Dec '24 ebitda of ₹ 188.75 crore. This represent the growth of 135.7%.
  • The net profit of Abbott India Ltd changed from ₹ 290.24 crore to ₹ 367.04 crore over 8 quarters. This represents a CAGR of 12.45% The net profit of Pfizer Ltd changed from ₹ 93.53 crore to ₹ 330.94 crore over 8 quarters. This represents a CAGR of 88.10% .
  • The Dividend Payout of Abbott India Ltd changed from 89.6 % on March 2020 to 72.53 % on March 2024 . This represents a CAGR of -4.14% over 5 yearsThe Dividend Payout of Pfizer Ltd changed from 296.54 % on March 2020 to 29.04 % on March 2024 . This represents a CAGR of -37.17% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
  • Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
  • The Primary Care division markets products in the areas of pain management and gastroenterology.

About Pfizer Ltd

  • Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
  • The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
  • It has its own manufacturing facility at Goa and Thane.
  • It has the distinction of being the first pharmaceutical company in India to start clinical research.
  • The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

Abbott India Ltd News Hub

News

Abbott India Ltd gains for fifth session

Abbott India Ltd gained for a fifth straight session today. The stock is quoting at Rs 311...

Read more

04 Jun 2025 13:00

News

Abbott India Ltd up for five straight sessions

Abbott India Ltd rose for a fifth straight session today. The stock is quoting at Rs 31190...

Read more

21 May 2025 13:00

News

Abbott India AGM scheduled

Abbott India announced that the 81th Annual General Meeting(AGM) of the company will be he...

Read more

16 May 2025 09:25

News

Board of Abbott India recommends final dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 1...

Read more

16 May 2025 09:25

News

Abbott India rises after Q4 PAT jumps 28% YoY to Rs 367 cr; declares dividend of Rs 475 /sh

Profit before tax (PBT) stood at Rs 482.71 crore in Q4 FY25, up 23.9% YoY. Total expenses ...

Read more

16 May 2025 10:58

News

Abbott India to conduct board meeting

Abbott India will hold a meeting of the Board of Directors of the Company on 15 May 2025. ...

Read more

07 May 2025 14:26

Pfizer Ltd News Hub

News

Pfizer to hold AGM

Pfizer announced that the 74th Annual General Meeting(AGM) of the company will be held on ...

Read more

21 May 2025 11:43

News

Board of Pfizer recommends final dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:47

News

Board of Pfizer recommends special dividend

75th year of Pfizer announced that the Board of Directors of the Company at its meeting he...

Read more

20 May 2025 12:46

News

Board of Pfizer recommends special dividend

Pfizer announced that the Board of Directors of the Company at its meeting held on 19 May ...

Read more

20 May 2025 12:46

News

Pfizer gallops after good Q4 outcome

Pfizer reported an exceptional profit of Rs 172.81 crore in Q4 March 2025, primarily due t...

Read more

20 May 2025 12:57

News

Volumes jump at Pfizer Ltd counter

BASF India Ltd, NLC India Ltd, Zensar Technologies Ltd, Newgen Software Technologies Ltd a...

Read more

20 May 2025 14:30

SWOT Analysis Of Pfizer Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Pfizer Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Abbott India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Abbott India Ltd and Pfizer Ltd

Which company has a larger market capitalization, Abbott India Ltd or Pfizer Ltd?

Market cap of Abbott India Ltd is 67,471 Cr while Market cap of Pfizer Ltd is 26,100 Cr

What are the key factors driving the stock performance of Abbott India Ltd and Pfizer Ltd?

The stock performance of Abbott India Ltd and Pfizer Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Abbott India Ltd and Pfizer Ltd?

As of June 9, 2025, the Abbott India Ltd stock price is INR ₹31751.1. On the other hand, Pfizer Ltd stock price is INR ₹5705.3.

How do dividend payouts of Abbott India Ltd and Pfizer Ltd compare?

To compare the dividend payouts of Abbott India Ltd and Pfizer Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions